glp-1 and suicidal ideation Association of glucagon-like peptide-1 receptor agonists with self-injury in individuals with diabetes and obesity: a propensity-weighted, population-based cohort study | Diabetologia FDA clears GLP-1 medications of

Food and Drug Administration (FDA) pushed back, claiming that the WHO caused undue alarm for consumers of aspartame

A 2023 JAMA study associates GLP-1 agonists with an increased risk of several conditions, including gastroparesis

Connect with a licensed provider to see if treatment is right for you

Better known by the brand names Wegovy and Ozempic, semaglutide is a once-weekly injectable medication that treats type 2 diabetes, obesity, and heart disease

Genesis Rivas is the Beauty Editor at Oprah Daily, where she covers hair, makeup, skin, nails, and more

The company urged that these cases either be incorporated into MDL 3094 or assigned as a new MDL under Judge Marstons oversight